Pfizer Inc. is a leading American multinational pharmaceutical and biotechnology corporation founded in 1849. It is headquartered at The Spiral in Manhattan, New York City. Pfizer is renowned for its innovation in developing revolutionary medicines that enrich and extend life by addressing a wide variety of diseases and health conditions.

The company’s portfolio includes products targeting both non-communicable diseases such as cancer and cardiovascular diseases, as well as communicable diseases including treatments for lower respiratory infections, tuberculosis, and HIV. Pfizer also focuses on rare diseases and gene therapy, aiming to provide treatments for conditions like Duchenne muscular dystrophy, hemophilia, sickle cell disease, and Gaucher disease.

Pfizer has a strong presence in vaccine development, having contributed historically to vaccines for diseases such as polio and smallpox. Currently, it invests heavily in vaccines for pneumococcal and meningococcal diseases, influenza, respiratory syncytial virus (RSV), Lyme disease, and Clostridioides difficile, along with maternal and neonatal vaccines and cancer prevention.

One of Pfizer’s notable recent advancements is in obesity treatment, specifically with the development of danuglipron, an oral GLP-1 receptor agonist designed to aid weight loss and blood sugar management. The company is undergoing clinical trials and optimization for this treatment to potentially expand its offerings in metabolic and cardiovascular therapeutics.

Pfizer holds a significant number of products recognized on the World Health Organization’s essential medicines list, underscoring its global impact in health care. Overall, Pfizer’s mission revolves around scientific innovation to create therapies that meet critical global health needs, reflecting its commitment to extending and improving quality of life worldwide.